Max Healthcare Institute Limited
MAXHEALTH · Hospitals · NSE
₹990
Current Market Price
Fair Value (DCF)
₹508
Margin of Safety
-48.6%
Updated just now
YieldIQ Score
25/100
Piotroski F-Score
6/9
Economic Moat
Moderate
Confidence
42%
ROE
11.5%
Debt/Equity
0.00
WACC
9.8%
Market Cap
₹0.96 Lakh Cr
Quality & Valuation
Neutral model outputs — no recommendations.
ROCE
11.6%
Return on capital employed
EV / EBITDA
45.1×
Enterprise multiple
Debt / EBITDA
1.5×
Leverage vs earnings
Interest Coverage
10.5×
EBIT covers interest
Current Ratio
0.88×
Short-term liquidity
Asset Turnover
0.49×
Revenue per ₹ of assets
Revenue CAGR (3Y)
21.3%
3-year revenue growth
Revenue CAGR (5Y)
26.2%
5-year revenue growth
DCF Scenario Analysis
vs CMP ₹989.5
Bear case
₹304.22
MoS -225.3%
Base case
₹508.16
MoS -94.7%
Bull case
₹683.57
MoS -44.8%
Ratio Trends
MAXHEALTH · last 5 annual periods
ROE
11.5%
ROCE
15.5%
Operating Margin
—
Debt / Equity
0.32×
PE
38.9×
EV / EBITDA
31.4×
Historical Financials
MAXHEALTH · Annual, last 5 years· amounts in ₹Cr unless noted
| Metric | 2021 | 2022 | 2023 | 2024 | 2025 | CAGR |
|---|---|---|---|---|---|---|
| Revenue | ₹2505 Cr | ₹3931 Cr | ₹4489 Cr | ₹5309 Cr | ₹6910 Cr | +28.9% |
| EBITDA | — | ₹1050 Cr | ₹1367 Cr | ₹1655 Cr | ₹1915 Cr | +16.2% |
| EBIT | ₹284 Cr | ₹840 Cr | ₹320 Cr | ₹356 Cr | — | +5.9% |
| PAT | ₹-138 Cr | ₹605 Cr | ₹1104 Cr | ₹1058 Cr | ₹1076 Cr | — |
| EPS (diluted) | ₹-1.59 | ₹6.24 | ₹2.58 | ₹2.58 | — | — |
| CFO | ₹118 Cr | ₹748 Cr | ₹1209 Cr | ₹1122 Cr | ₹1459 Cr | +87.6% |
| CapEx | — | — | — | — | ₹-966 Cr | — |
| FCF | — | — | — | — | ₹494 Cr | +0.0% |
| Total Assets | — | ₹9189 Cr | ₹10.1K Cr | ₹12.0K Cr | ₹15.2K Cr | +13.4% |
| Total Debt | — | — | ₹84.5 Cr | ₹110 Cr | ₹3010 Cr | +144.3% |
| Shareholders' Equity | — | — | ₹7410 Cr | ₹8408 Cr | ₹9381 Cr | +6.1% |
CAGR computed across the visible window. Signs reverse if start value is zero or negative.
Peer Comparison
MAXHEALTH vs 5 closest peers by market-cap band
| Peer | MoS | Score | Verdict | ROE | PE |
|---|---|---|---|---|---|
| APOLLOHOSP APOLLOHOSP | — | — | Pending | 16.7% | 65.8× |
| FORTIS Fortis Healthcare Limited | -49.5% | 43 | Overvalued | 8.4% | — |
| NH NH | — | — | Pending | 21.8% | — |
| ASTERDM ASTERDM | — | — | Pending | 147.3% | — |
| MEDANTA MEDANTA | — | — | Pending | 14.2% | — |
Click a ticker to view its fair-value analysis.
Dividend History
3 ex-dividend events on file. Source: NSE corporate-actions feed.
Total paid (5Y)
₹4.00/sh
Last payout
2025-07-04
₹1.50
Peak payout
₹1.50
Trailing yield
0.15%
Amounts parsed from NSE subject lines; percent-of-face-value declarations are not converted and shown as missing.
AI Analysis Summary
Model-generated description of metrics. Not investment advice. Max Healthcare Institute Limited (MAXHEALTH.NS) trades at 989.50 vs a model fair value of 508.16, a gap of -48.6%. Piotroski F-score: 6/9...
Read full AI analysis →Reverse DCF
Market-implied growth
What FCF growth is priced in →
Risk Analysis
Volatility & drawdown
Risk profile of MAXHEALTH →
DuPont
ROE decomposition
Why ROE is what it is →
Technicals
RSI, MACD, MAs
Reference indicators →
News & Filings
Recent activity
BSE filings + news for MAXHEALTH →
Compare
Head-to-head with peers
Compare MAXHEALTH side by side →
Run Full Interactive Analysis
Interactive DCF sliders, sensitivity heatmap, peer comparison, and more.
Analyse MAXHEALTHNow →Model estimates using publicly available data. Not investment advice. YieldIQ is not registered with SEBI as an investment adviser or research analyst. Past performance does not guarantee future results.